Answers are grounded in this paper and cite their sources.
To evaluate the effect of intraureteral 2% lidocaine hydrochloride (HCl) gel administration on postoperative pain and analgesic requirements following ureteroscopy (URS). A total of 307 patients who underwent URS with double-J stenting for ureteral stones between January 2023 and February 2024 were evaluated. After excluding potential confounding factors, patients were divided into two groups based on intraureteral 2% lidocaine HCl gel instillation at the end of the procedure: the 2% lidocaine HCl gel group ( n = 197) and the control group without gel administration ( n = 110). Postoperative pain intensity was evaluated using the Visual Analog Scale (VAS) at the 2nd and 6th hours, and postoperative analgesic requirement was also assessed. Baseline demographic and preoperative clinical characteristics were comparable between the groups (all p > 0.05). Postoperative pain scores were significantly lower in the 2% lidocaine HCl gel group at both time points. At the 2nd postoperative hour, mean VAS scores were 1.68 ± 1.14 versus 3.62 ± 1.79, and at the 6th hour, 1.43 ± 1.37 versus 2.58 ± 1.61 in the 2% lidocaine HCl gel and control groups, respectively (both p < 0.01). Rescue analgesia was required less frequently in the 2% lidocaine HCl gel group (43.15% vs. 74.55%, p < 0.01) and total parenteral paracetamol consumption was significantly lower (0.88 ± 1.07 g vs. 1.49 ± 0.98 g, p = 0.01). Multivariable logistic regression analysis identified ASA classification and intraureteral 2% lidocaine HCl gel administration as independent predictors of postoperative pain at both time points (all p < 0.01). Intraureteral administration of 2% lidocaine HCl gel was associated with lower early postoperative pain scores and reduced analgesic requirements following URS with double-J stenting.
No takes yet. Share an insight, caveat, or question.
Coser et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: